Work

Antinociception following 1,3,-di-o-tolylguanidine, a selective σ receptor ligand

Year: 1995

Type: article

Source: Pharmacology Biochemistry and Behavior

DOI: 10.1016/0091-3057(94)00346-7

Authors: Jeffrey S. Mogil, Wendy F. Sternberg, Robert N. Pechnick, John C. Liebeskind, Benjamin Kest

Institutions: University of California, Los Angeles, Portland VA Medical Center, Louisiana State University

Language: English

Topic: Pharmacological Receptor Mechanisms and Effects

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Bristol-Myers Squibb, National Institutes of Health, National Institute of Mental Health, National Institute of Neurological Disorders and Stroke

Awards: G4094242795, Research Training: Psychobiological Sciences, BEHAVIORAL AND ELECTROPHYSIOLOGICAL STUDIES OF PAIN

OpenAlex ID: W2085210936

FWCI: 0.354

Cites: 64

Cited by: 16

Related to: 10